title: Subdermal contraceptive implants in nurse-midwifery practice.
abstract: Subdermal contraceptive implants have only recently been approved for use in the United States. At present, only one subdermal contraceptive implant, Norplant, is approved in the United States. This article describes the development of Norplant, its efficacy and safety, a description of the system, education for clients, side effects, indications and contraindications, insertion and removal, incorporation into midwifery practice, and education for health professionals regarding its use.
authors: Center for Addiction and Pregnancy (CAP), Francis Scott Key Medical Center, Baltimore, Maryland.
authors: J M
authors: JM
authors: Emerling
authors: P
authors: P
authors: Paluzzi
authors: J
authors: J
authors: Leiva
authors: V E
authors: VE
authors: Cullins
mesh_terms: D004343:Drug Implants; D005193:Family Planning Services / Q000379:methods*; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009721:Nurse Midwives / Q000193:education; D010347:Patient Care Planning / Q000592:standards; D010353:Patient Education as Topic / Q000379:methods
chemical_list: D004343:Drug Implants; D016912:Levonorgestrel